Direct comparison
5 Panel vs 10 Panel Drug Test: Analytes, Cutoffs
What a 5-panel or 10-panel drug test label means, why cutoffs are set per drug, and what the federal 49 CFR 40.85 table and FDA say. Not medical advice.
Written and maintained by CASRAI Editorial Board
Last updated
Ask CASRAI · free to try
Ask about 5 Panel vs 10 Panel Drug Test: Analytes, Cutoffs
Ask your first 2 questions free below. Subscribers get 150 a day for $29 a month.
An AI assistant specialized in research administration. It cites the sources behind every answer, labels web answers and says when it can't answer.
Answers draw on CASRAI's guides and dictionary plus the federal and funder documents we index: Federal Register, Grants.gov, Regulations.gov and UKRI.
Works on this site and inside Claude, Cursor and the AI tools you already use.
Everything CASRAI publishes — this page, the dictionary, the guides and the news — stays free to read, with no account and no card.
How do 5-panel test, 10-panel test (also 12-panel cups) compare side by side?
The table below compares 5-panel test, 10-panel test (also 12-panel cups) across 10 procurement-relevant dimensions, from what the number means through source.
Side-by-side comparison
| Dimension | 5-panel test | 10-panel test (also 12-panel cups) |
|---|---|---|
| What the number means | A commercial label for a test covering about five drug classes. It is not defined in 49 CFR Part 40 or on the FDA drugs of abuse page. | A commercial label for a longer menu. No source read defines it, and 12-panel cups are the same idea with more analytes. |
| Analytes listed | Commonly the five classes of the federal laboratory table: marijuana metabolite, cocaine metabolite, opiates, amphetamines and phencyclidine. Confirm on the device. | The same classes plus extra drugs that differ by provider. Do not assume a universal list; read the insert. |
| Cutoff per analyte | Set per drug. In the federal laboratory table the initial cutoffs are 50 ng/mL for marijuana metabolites (THCA), 150 for the cocaine metabolite (benzoylecgonine), 2000 for codeine/morphine, 300 for hydrocodone/hydromorphone, 100 for oxycodone/oxymorphone, 10 for 6-acetylmorphine, 25 for phencyclidine, and 500 for amphetamine/methamphetamine and MDMA/MDA. | Also set per drug, not per panel. Adding analytes adds cutoffs; it does not change the cutoff of a drug already on the list. A non-federal device may use its own cutoffs, printed in its insert. |
| Confirmatory cutoffs (federal table) | THCA 15 ng/mL, benzoylecgonine 100, codeine and morphine 2000 each, hydrocodone and hydromorphone 100 each, oxycodone and oxymorphone 100 each, 6-acetylmorphine 10, phencyclidine 25, amphetamine and methamphetamine 250 each, MDMA and MDA 250 each. | The same federal table applies only to the drugs it lists; drugs outside it have no entry in 49 CFR 40.85. |
| Below / at or above the cutoff | Under 49 CFR 40.85 and the laboratory rule that follows it, an initial result below the cutoff is reported negative; at or above the cutoff, a confirmation test is required. | The same logic describes the federal laboratory process. Whether a non-federal device or program follows a confirmation step is set by its own instructions. |
| Is it more accurate? | Panel size says nothing about accuracy. Cutoff, specimen and confirmation testing are what the sources address. | A longer panel screens for more drugs; no source read ties a higher panel count to better accuracy. |
| FDA review status | FDA reviews many drugs of abuse tests before sale and keeps a database of tests cleared for over-the-counter use. It generally does not review tests labeled solely for employment and insurance testing. | Same FDA page applies; check the labeling for the intended-use statement and the FDA database for the specific product. |
| Collection device vs test | A device that only collects a specimen for laboratory testing is regulated separately: 21 CFR 864.3260 covers OTC sample collection systems, Class I (general controls). | Same distinction: a multi-analyte cup that reads results on the spot is a test; a collection system sends the specimen to a laboratory. |
| When to pick each | When the program requires only the federally regulated drug classes, or the program document names a 5-panel. | When the program document lists additional drugs beyond the federal set. Match the analyte list to the program, not to the panel number. |
| Source | eCFR 49 CFR 40.85, read 2026-10-31: https://www.ecfr.gov/current/title-49/part-40/section-40.85 . FDA Drugs of Abuse Tests, read 2026-10-31: https://www.fda.gov/medical-devices/in-vitro-diagnostics/drugs-abuse-tests | eCFR 21 CFR 864.3260, read 2026-10-31: https://www.ecfr.gov/current/title-21/chapter-I/subchapter-H/part-864/subpart-D/section-864.3260 . FDA Drugs of Abuse Tests: https://www.fda.gov/medical-devices/in-vitro-diagnostics/drugs-abuse-tests |
Common questions
Common questions about 5-panel test vs 10-panel test (also 12-panel cups)
Is a 10-panel drug test more accurate than a 5-panel?
+
No source read ties panel count to accuracy. A 10-panel checks more drugs; what governs a result for each drug is its cutoff concentration and whether a non-negative screen is confirmed by laboratory testing.
What are drug test cutoff levels?
+
A cutoff is the concentration, in ng/mL, at or above which a drug result is not reported negative. In the federal laboratory table (49 CFR 40.85) each analyte has an initial cutoff and a lower or equal confirmatory cutoff, for example THCA 50 ng/mL initial and 15 ng/mL confirmatory (read 2026-10-31).
Does a 12-panel drug test cup change the cutoffs?
+
Having more analytes on a cup adds more cutoffs; it does not change the cutoff of any one drug. Each analyte has its own cutoff, and non-federal devices state theirs in the instructions for use, so read the insert for the specific cup.
What happens when a result is at or above the cutoff?
+
For a federal laboratory initial test, a result below the cutoff is reported negative and a result at or above it must be followed by a confirmation test (49 CFR 40.85, read 2026-10-31). Other programs follow their own written procedure.
Does FDA review drug test cups?
+
FDA reviews many drugs of abuse tests before they are sold, but generally not tests whose labeling says they are intended solely for employment and insurance testing. It also maintains a database of tests cleared for over-the-counter use (FDA, read 2026-10-31).
Going deeper
